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ABSTRACT
The objective of this study was to develop and characterize a novel intravaginal membrane 
platform for pH-triggered release of nanoparticles (NPs), which is essential for efficient 
  
intravaginal delivery of certain effective but acid-labile therapeutic agents for sexually 
transmitted infections, such as small interfering RNA (siRNA). pH-responsive polyurethane 
(PU) was electrospun into a porous nanofibrous membrane. The diameters of the fibers, as well 
as the thickness and pore sizes of the membrane under dry and wet conditions (pH 4.5 and 7.0), 
were determined from scanning electron microscopy (SEM) micrographs. pH-dependent zeta-
potential (ζ) of the membrane was evaluated using a SurPASS electrokinetic analyzer. 
VisiblexTM color-dyed polystyrene NPs (PSNs, 200 nm, -COOH) and CCR5 siRNA-
encapsulated solid lipid NPs (SLNs) were used for in vitro NP release studies in a vaginal fluid 
simulant (VFS) at pH 4.5 (normal physiological vaginal pH) and 7.0 (vaginal pH neutralization 
by semen). During 24 hours of incubation in VFS, close-to-zero PSNs (2 ± 1%) and 28 ± 4% 
SLNs were released through the PU membrane at pH 4.5, whereas the release of PSNs and SLNs 
significantly increased to 60 ± 6% and 59 ± 8% at pH 7.0, respectively. The pH-responsive 
release of NPs hinged on the electrostatic interaction between the pH-responsive membranes and 
the anionic NPs, and the change in pH-responsive morphology of the membrane. In vitro 
biocompatibility studies of the membranes showed no significant cytotoxicity to VK2/E6E7 
human epithelial cells and Sup-T1 human T-cells and no significant changes in the expression of 
pro-inflammatory cytokines (IL-6, IL-8, and IL-1β). Overall, these porous pH-responsive PU 
membranes demonstrated their potential in serving as “window” membranes of reservoir-IVRs 
for pH-responsive intravaginal release of NPs.
Keywords: pH-responsive release of nanoparticles; smart intravaginal delivery; pH-responsive 
polyurethane; electrospun pH-responsive membrane; controlled drug delivery
1. Introduction
  
More than 30 million people globally live with human immunodeficiency virus (HIV) 
infection that can potentially progress to acquired immunodeficiency syndrome (AIDS) [1,2]. 
HIV is a life-threatening disease, and no cure has been found to date. Prevention and early 
treatment are important for decreasing the prevalence and incidence of HIV.
Intravaginal drug delivery is beneficial for HIV prevention because unprotected 
heterosexual intercourse is the typical route of HIV transmission. Moreover, the advantages of 
intravaginal drug delivery include increased drug delivery efficiency to the target site, drug 
bioavailability, pharmacological response, and drug compliance of patients [3,4]. Intravaginal 
formulations such as ointments, creams, gels, films, vaginal tablets, and intravaginal rings 
(IVRs) have been developed for the release of drugs [5]. Among intravaginal formulations, IVRs 
have advantages over other vaginal formulations because they can provide sustained controlled 
drug release for a prolonged period [6]. The availability of the intravaginal formulations could 
greatly empower women to protect themselves from infection because the application of 
formulations does not require the consent of their partner [7].
Anti-HIV drugs and small interfering ribonucleic acids (siRNAs) act on T cells at 
different stages of the HIV life cycle, including receptor interaction, virus–cell fusion, reverse 
transcription, integration, and proteolytic processing to block the transmission progress [8,9]. 
Hydrophilic anti-HIV drugs have advantages because of their solubility in an aqueous 
environment in comparison to the poorly water-soluble anti-HIV drugs. However, it is 
cumbersome to achieve a high delivery efficiency of hydrophilic anti-HIV drugs to T cells 
because the drugs cannot effectively penetrate through the vaginal mucus barrier and cross the 
lipid bilayer of the cell membrane [10,11]. On the other hand, poorly water-soluble anti-HIV 
drugs have a limitation in their application because of their relatively low solubility and 
  
bioavailability in an aqueous environment [12]. Similarly, siRNAs have a high potential to 
prevent HIV transmission by simultaneously targeting host genes and viral genes [13], but they 
have low stability in the acidic vaginal environment.
In this regard, an alternative method is needed to deliver anti-HIV drugs and siRNAs to 
increase the delivery efficiency and reduce side effects [14]. Drug delivery systems (DDS) using 
nanocarriers such as micelles, vesicles, solid lipid nanoparticles (SLNs), and liposomes have 
been developed for the delivery of drugs and genes [15,16]. A nanocarrier can improve 
dispersion of poorly water-soluble anti-HIV drugs, protect cargos from the acidic conditions, and 
increase delivery efficiency [17,18]. DDS using nanocarriers can also reduce systemic toxicity 
and off-target effects of HIV treatment [19].
Although nanocarriers are beneficial for the intravaginal delivery of anti-HIV drugs and 
siRNA, a continuous release of drugs and siRNAs is not desirable. For prevention of HIV, it is 
desirable for the anti-HIV drug- or siRNA-loaded nanocarrier to be released only during the 
heterosexual intercourse to avoid unnecessary exposure to drug and reduce side effects. 
Therefore, it is necessary to release nanocarriers from IVRs upon pH change from 4.5 to 7.0 
because vaginal pH can be increased to neutral pH from normal acidic vaginal pH (pH 3.5-4.5) 
by the introduction of the seminal fluid during heterosexual intercourse [20–24].
Our research group fabricated solvent-cast pH-responsive PU membranes to serve as 
“window” membranes of reservoir-IVR [25]. The solvent-cast membranes showed a continuous 
release of the hydrophilic model drug “diclofenac sodium” (NaDF) at pH 7.0 but close-to-zero 
release of NaDF at pH 4.5. Although the solvent-cast pH-responsive PU membranes 
demonstrated on-demand drug release, the membranes failed to achieve pH-responsive 
permeation of nanoparticles (NPs) due to the insufficient interconnected space for NPs. In this 
  
study, our research group proposed the fabrication of electrospun pH-responsive interconnected 
porous PU membranes as “window” membranes of reservoir-IVR for on-demand release of NPs.
Stimuli-responsive membranes have been developed for various types of applications 
including drug delivery devices and separation processes [26]. For example, a thermo- and pH-
responsive composite membrane composed of poly(N-isopropylacrylamide-co-methacrylic acid) 
was investigated for permeability change triggered by environmental stimuli [27]. The 
permeability of vitamin B12 was increased with increasing temperature or decreasing pH. The 
pH-responsive permeation change of vitamin B12 was supported by change in pore size of the 
membrane due to swelling and shrinking of the polymer chains. Similarly, a pH-responsive 
electrospun membrane was fabricated using a mixture of poly(vinyl alcohol) and poly(acrylic 
acid) [28]. The membrane demonstrated a pH-responsive change in swelling ratio and thickness 
increase with increasing pH. Likewise, a pH-responsive gating membrane system with a 
pumping effect consisting of a porous membrane and cross-linked hydrogel has also been studied 
[29]. The porous membrane was fabricated using PVDF and conjugated with PMAA chains on 
its surface. Moreover, the hydrogel is prepared by plasma-graft pore-filling polymerization of 
poly(N,N-dimethylaminoethyl methacrylate) (PDM) for the inside of the reservoir as a pumping 
material. When pH is lower than the pKa of PMAA (4.65–5.35) and protonated PDM (4.5–5.5), 
the release is accelerated by the shrinking of PMAA chains and the swelling of the PDM 
hydrogel. In addition, a pH-responsive switchable membrane was fabricated by the self-assembly 
of polystyrene-b-poly(4-vinylpyridine) in the presence of metal ions [copper(II), cobalt(II), 
nickel(II), and iron(II)] and by nonsolvent-induced phase separation [30]. This membrane 
demonstrated change in pH-responsive pore size (larger pore size at pH 10.0 than at pH 2.0), 
water flux change, and permeation of polyethylene glycol (PEG; Mw 1,500-10,000) (higher 
  
permeation at pH 7.0 than at pH 2.0). However, to the best of our knowledge, no study has 
reported pH-responsive release of NPs from a reservoir.
In the present study, a pH-responsive interconnected porous PU membrane was 
developed for smart intravaginal release of NPs. The pH-responsive PU membrane was 
fabricated by electrospinning to facilitate the fabrication of thin interconnected porous 
membranes. The permeability of a polystyrene model NP and a CCR5 siRNA-loaded SLN 
through the electrospun porous membrane was controlled by changing the pH-responsive 
morphology of the membrane and electrostatic interaction between the membrane and the NPs. 
Therefore, this is the first study to develop a pH-responsive membrane for stimuli-responsive 
intravaginal release of NPs to achieve smart drug delivery. The pH-responsive interconnected 
porous PU membrane has potential utility for drug delivery from medical devices including 
IVRs.
2. Materials and methods
2.1. Materials
1,1,1,3,3,3-Hexafluoro-2-propanol (HIFP, 99.99%), 1,4-Bis(2-hydroxyethyl)piperazine 
(HEP, 99%), 1,6-hexanediol (HD, 99%), 4,4′-Methylenebis(phenyl isocyanate) (MDI, 98%), 
anhydrous 1,2-dichloroethane (DCE, 99.8%), anhydrous diethyl ether (>99%), anhydrous N,N-
dimethylformamide (DMF, 99.8%), dibutyltin dilaurate (DBTDL, 95%), dimethyl sulfoxide 
(DMSO, ≥99.5%), propylene glycol (PG, >99.5%), and tetrahydrofuran (THF) were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Polyethylene glycol (Mw = 6,000) was purchased 
from EMD Chemicals (Mississauga, ON, Canada). VisiblexTM color-dyed polystyrene 
nanoparticles (PSNs, 200 nm, COOH on its surface, media: 0.1% Tween 20 in deionized water) 
was purchased from Phosphorex Inc. (Hopkinton, MA, USA). C12-HPC(2-(4,4-Difluoro-5-
  
Methyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Dodecanoyl)-1-Hexadecanoyl-sn-Glycero-3-
Phosphocholine) was purchased from Thermo Fisher Scientific (Asheville, NC, USA). Vaginal 
fluid simulant (VFS) was prepared by dissolving 1.0 g acetic acid, 0.018 g bovine serum 
albumin, 0.222 g Ca(OH)2, 0.6 g glycerol, 5.0 g glucose, 1.4 g KOH, 2.0 g lactic acid, 3.51 g 
NaCl, and 0.4 g urea in 1 L of distilled water. The pH of VFS was adjusted by adding 0.1 N HCl 
or 0.1 N NaOH solution [31].
2.2. Synthesis of pH-responsive polyurethane copolymers
pH-responsive and non-responsive polyurethane (PU) copolymers were synthesized and 
purified according to a procedure reported previously [25]. Briefly, a three-neck round-bottom 
flask was set up with nitrogen inlet–outlet purging to synthesize pH-responsive PU (PEG-HEP-
MDI-PG). PEG and 1,4-Bis(2-hydroxyethyl)piperazine (HEP) (feed mole ratio of PEG: HEP = 
0.1:0.9) were dissolved in anhydrous 1,2- dichloroethane and added to the reactor. A catalytic 
amount of DBTDL and a stoichiometric ratio of diisocyanate (MDI, feed mole ratio of OH/NCO 
= 1) were added to the reactor. The reactor was maintained at 60 °C for 3 h with stirring under a 
nitrogen atmosphere. After the reaction, PG (feed mole ratio of HEP:PG = 0.9:1.0) and a 
stoichiometric ratio of diisocyanate (MDI, OH/NCO = 1) were added. The reactor was 
maintained at 60 °C for 3 h under nitrogen atmosphere. The product was then precipitated in 8-
fold diethyl ether and washed with excess diethyl ether. The product was redissolved in DMSO, 
reprecipitated in 8-fold distilled water, and washed with excess distilled water several times to 
remove remaining impurities. HD was used to synthesize control non-pH-responsive PU (PEG-
HD-MDI-HD) instead of HEP and PG. The overall feed mole ratio of raw chemicals for PEG-
HDI-MDI-HD was PEG:HD:MDI = 0.1:2.9:3.0. The viscosity average molecular weight (Mv) of 
the synthesized PEG-HEP-MDI-PG and PEG-HD-MDI-HD copolymer was calculated from the 
  
Mark–Houwink equation ([η] = 3.64 × 10-4 M0.71) for the polyether-PU in DMF at 25 °C [32]. A 
Cannon–Ubbelohde dilution viscometer was used to measure viscosities in a constant 
temperature bath set at 25.0 ± 0.5 °C. Pure DMF and 25 mg of PU in 10 mL of DMF were 
prepared for measurement. The PU solution was diluted from 2.50 mg/mL to 1.25 mg/mL. 
Travel times of pure DMF and polymer solutions between two measurement marks were 
recorded. Mv values of PEG-HEP-MDI-PG and PEG-HD-MDI-HD were 1.23 × 106 and 2.36 × 
106, respectively.
2.3. Electrospinning of pH-responsive polyurethane copolymers
pH-responsive PU (PEG-HEP-MDI-PG) was electrospun to fabricate fibrous, 
interconnected, and porous PU membranes using an electrospinning apparatus (Ne300, Inovenso, 
Istanbul, Turkey). Different mixing ratios of DMF and THF were applied to determine the most 
suitable electrospinning conditions for fabricating a fibrous pH-responsive PU membrane. The 
viscosity of the pH-responsive PU solution was evaluated using an Advanced Rheometer (AR 
2000, TA Instruments) and was calculated from the relationship between shear stress and shear 
rate at 0.1-100 rad/s using 20 mL of 20 wt% PU solutions. The concentration of PU in mixed 
solvents (20 wt%), voltage applied on the nozzle (30 kV), feeding speed of the pH-responsive 
PU solution (0.7 mL/h), nozzle-to-collector distance (15 cm), and dispensed volume of the PU 
solution (1 mL) were all fixed for electrospinning. These electrospun pH-responsive PU 
membranes were washed with excess distilled water to remove remaining impurities and then 
dried at room temperature.
Control PU (PEG-HD-MDI-HD) membranes were fabricated using a custom-designed 
electrospinning setup with the following conditions: 9% w/v solution in HFIP, needle-to-
collector distance of 18 cm, flow rate of 1 mL/h, voltage of 15 kV, and a 21-gauge needle. The 
  
needle was clamped to the positive electrode of a high-voltage power supply (ESP200D, 
NanoNC, Seoul, South Korea), whereas the negative electrode was connected to a rotating 
aluminum drum collector (250 rpm). The solution was delivered using a syringe pump 
(ESP200D). Electrospun nanofibers were dried in a vacuum oven at ambient temperature for 3 
days and stored in a desiccator for subsequent use.
Scanning electron microscope (SEM; FEI Quanta ESEM) images of the fabricated PU 
membranes were captured to evaluate the diameter (DI) of fibers, pore size, and thickness of the 
membranes [33–36]. Membrane samples were coated with 10 nm Au-Pd before capturing 
images. The DI, pore size, and thickness were manually measured using ImageJ, a free photo 
editing software program, from SEM images using their size bar as reference [37]. The threshold 
of pores was set to the blackest area versus the gray area using SEM images at ×1000 
magnification.
2.4. Physicochemical characterization of electrospun porous pH-responsive PU membrane
Changes in the pH-responsive morphology (pore size, thickness, and DI) of electrospun PU 
membranes were evaluated from SEM images. For evaluation, electrospun porous pH-responsive 
(DMF:THF = 3:7) and control PU membranes were cut into 2 × 2 cm squares and immersed in 
VFS at pH 7.0 or pH 4.5 at 37 °C for 3 h with gentle shaking. Swollen samples were extracted 
from VFS and kept at -80 °C followed by lyophilization. Fracture surfaces of these electrospun 
PU membranes for cross-section imaging were prepared by cracking membranes under liquid 
nitrogen.
The streaming current was measured for the electrospun PU membranes using a SurPASS 
electrokinetic analyzer (Anton Paar) at pH ranging from 3.5 to 8.5 [38–40]. Rectangular 
membrane samples (20 mm × 10 mm) were prepared and attached to sample holders using a 
  
double-sided adhesive tape. The measurement was taken with an adjustable-gap cell, and the 
flow channel gap was set at 100 µm. As a background electrolyte, 1 mM KCl solution was used, 
and the pH was adjusted using 0.05 M HCl or 0.05 M NaOH solution. Zeta-potential (ζ) of the 









where dI/dP is the slope of the streaming current versus pressure, µ is the solution dynamic 
viscosity, ɛ is the dielectric constant of the solution, ɛ0 is the vacuum permittivity, L is the 
streaming channel length, and A is the cross-section of the streaming channel.
2.5. Nanocarrier permeability studies using a model nanoparticle (PSNs, -COOH)
Commercially available blue-dyed PSNs (-COOH) were used for conducting pH-
responsive NP release tests. Before release studies, the average particle size of PSNs was 
evaluated by dynamic light scattering (DLS) using a ZetaPALS potential analyzer (Brookhaven 
Instrument, Holtsville, NY, USA). Then, PSNs 0.1 μg/mL in VFS at pH 4.5 and 7.0 were 
prepared by vortex shaking for 3 min at 3,000 rpm. The pH of PSN suspension in VFS was 
adjusted by adding 0.1 N HCl or NaOH solution. A scattering angle of 90° and laser light at 659 
nm were applied for DLS measurement.
The ZetaPALS potential analyzer was used to evaluate the zeta-potential of PSNs. Two 
suspensions of PSNs (0.1 µg/mL) in distilled water (one at pH 4.5 and another at pH 7.0) were 
prepared. The pH of the suspension was adjusted using 0.1 N HCl or 0.1 N NaOH solution. A 
Smoluchowski model was used to evaluate surface charge.
pH-responsive NP release studies were performed using Franz cells. Briefly, electrospun 
porous pH-responsive (DMF: THF = 3: 7) and control PU membranes were cut into 2×2 cm 
  
squares and sandwiched between the upper and bottom chambers of Franz cells. Three 
suspensions of PSNs at 1 mg/mL (at pH 4.5, pH 5.5, and pH 7.0) in VFS were prepared for the 
upper chamber of Franz Cells. The bottom chamber was filled with VFS of pH same as that in 
the upper chamber. The bottom chamber was kept at 37 °C. The VFS in the bottom chamber was 
gently stirred with a magnetic bar. After adding 800 µL of the prepared PSN suspension to the 
upper chamber of Franz cells, 300 µL of the sample solution was collected to evaluate released 
amounts of PSNs at 1, 2, 3, 6, 12, and 24 h from each arm of Franz cells. The amount of PSN 
released was quantified by reading absorbance at 300 nm using a plate reader.
The amounts of PSNs associated with electrospun porous PU membranes (DMF:THF = 
3:7) in VFS at pH 4.5, 5.5, and 7.0 were evaluated. Round-cut pH-responsive and control PU 
membranes (DI: 0.8 cm) corresponding to an area of 0.5024 cm2 between the upper and bottom 
chambers of Franz cells were prepared. Prepared electrospun PU membrane samples were 
immersed in 6.4 mL of 0.125 mg/mL PSN suspension at 37 °C with gentle horizontal shaking 
(100 rpm) because 0.8 mL of 1 mg/mL PSNs was used for the upper chamber, whereas 5.6 mL 
of the release medium (in VFS at pH 4.5, 5.5, or 7.0) was used for the bottom chamber of Franz 
cells to evaluate the pH-responsive NP release. At each time point (1, 2, 3, 6, 12, and 24 h), 300 
μL of the sample solution was taken to evaluate the amount of PSNs associated with electrospun 
PU membranes (DI: 0.8 cm). Fresh VFS was replenished for the suspension. The concentration 
of free PSNs was quantified by measuring absorbance at 300 nm using a plate reader. The 
percentage of PSNs associated with the membranes was back-calculated using the concentration 
of free PSNs.
2.6. Nanocarrier permeability studies using CCR5 siRNA-encapsulated solid lipid nanoparticles 
(SLNs)
  
CCR5 siRNA-encapsulated SLNs were prepared by the emulsion solvent diffusion method 
described elsewhere, with slight modification [41]. Briefly, 2.5 mg of glyceryl monostearate 
(Sigma-Aldrich, MO, USA), 5 mg of ∝-L-phosphatidylcholine (Soy-95%) (Avanti Polar Lipids, 
AL, USA), and 20 µg of fluorescently labeled BODIPY-phosphocholine(C12-HPC(2-(4,4-
Difluoro-5-Methyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Dodecanoyl)-1-Hexadecanoyl-sn-Glycero-
3-Phosphocholine) were dissolved in 700 µL of acetone and ethanol heated at 55 ºC. Twenty-
five micrograms of CCR5 silencer siRNA (Thermo Fisher Scientific, Asheville, NC, USA) was 
condensed using polyethylene imine and added to the dissolved lipid mixture. The mixture was 
sonicated for 20 s, thereby resulting in the formation of the first emulsion. The first emulsion was 
emulsified with 2% polyvinyl alcohol (8 mL) (Sigma-Aldrich, MO, USA) and sonicated for 60 s. 
The NPs were stirred for 8 h to evaporate the organic solvent and were collected by 
centrifugation. The supernatant was collected to determine the encapsulation efficiency, and the 
SLNs were washed 3 times. The SLNs were resuspended in mannitol (1:1 ratio w/w) and freeze-
dried.
pH-responsive release studies were performed using the CCR5 siRNA-encapsulated 
SLNs. Briefly, electrospun porous pH-responsive (DMF:THF = 3:7) membranes were cut into 2 
× 2 cm squares and sandwiched between the upper and bottom chambers of Franz cells. Before 
use, the freeze-dried CCR5 siRNA-encapsulated SLNs were resuspended in distilled water at 1 
mg/mL and washed with distilled water three times to remove mannitol. Two suspensions of 
CCR5 siRNA-encapsulated SLNs at 1 mg/mL (at pH 4.5 or pH 7.0) in VFS were prepared for 
the upper chamber of Franz Cells. The bottom chamber was filled with VFS of the same pH as 
that in the upper chamber and was kept at 37 °C. After adding 800 µL of the prepared CCR5 
siRNA-encapsulated SLN suspension to the upper chamber of Franz cells, 300 µL of the sample 
  
solution was collected to evaluate released amounts of CCR5 siRNA-encapsulated SLNs at 1, 2, 
3, 6, 12, and 24 h from each arm of Franz cells. The amount of CCR5 siRNA-encapsulated SLNs 
released was quantified by reading fluorescence at excitation 544 nm and emission 590 nm using 
a plate reader.
2.7. In vitro biocompatibility studies of electrospun porous pH-responsive PU membrane
The electrospun porous pH-responsive PU membrane (DMF:THF = 3:7) was evaluated 
on the vaginal epithelial cells VK2/E6E7 and the immune cells Sup-T1 for its cell toxicity and 
also for the production of the pro-inflammatory cytokines. To assess cytotoxicity, we used the 
elution assay method followed by the cell proliferation assay MTS (CellTiter 96® AQueous One 
Solution Cell Proliferation Assay, Promega Corporation, Madison, WI, USA) because the elution 
test methods are widely applied for in vitro cytotoxicity testing of biocompatible materials 
including PU [42–44]. Briefly, 50 mg of the electrospun membrane sterilized in 70% isopropanol 
for 10 s, dried, and exposed to UV light for 1 h was incubated in 2.5 mL of either VK2/E6E7 cell 
medium consisting of keratinocyte serum-free medium (K-SFM) containing 0.1 μg/mL 
recombinant human epidermal growth factor, 50 mg/mL bovine pituitary extract, 0.4 mM of 
calcium, and 1% of penicillin/streptomycin or Sup-T1 cell medium consisting of RPMI-1640 
containing 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin. The 
polymer was incubated for 1, 7, 15, and 30 days at 37 °C in an orbital shaker set at 100 rpm. At 
different time points, all the media were collected aseptically and used to treat 2.5 x 105 
VK2/EE67 cells or Sup-T1 cells seeded in a 96-well plate and maintained at 37 °C under 5% 
  
CO2 for 24 h. Blank K-SFM or RPMI-1640 medium was used as negative the control and 1 M 
acrylamide prepared in K-SFM or RPMI-1640 was used as the positive control.
In addition, 50 μg/mL of lipopolysaccharide (LPS; Thermo Fisher Scientific, MA, USA) 
and 200 μg/mL of nonoxyl-9 (N-9, Spectrum Chemical, Corp., New Brunswick, NJ, USA) were 
prepared with K-SFM or RPMI-1640 and used to treat VK2/E6E7 cells or Sup-T1 cells as the 
positive control for the pro-inflammatory markers interleukin-6 (IL-6), interleukin-8 (IL-8) 
(induce by LPS), and interleukin-1 beta (IL-1β) (induced by N-9). After 24 h of treatment, the 
supernatant in each well was collected for a downstream ELISA assay for evaluating the pro-
inflammatory markers and was replenished with fresh medium. Twenty microliters of the MTS 
reagent was added in each well, and the plate was incubated as specified in the MTS assay 
protocol, and cell viability was analyzed by reading the absorbance at 450 nm using a Synergy 
HT Multiplate Reader (BioTek, Winooski, VT, USA). ELISA kits obtained from R&D Systems 
(Minneapolis, MN, USA) were used to evaluate IL-6, IL-8, and IL-1β production. The 
absorbance of each ELISA plate was read at 450 nm using a microplate reader.
2.8. Statistical analysis
Data are presented as mean ± standard deviation (SD). The number of replicates is 
indicated as the n-value. One-way analysis of variance was performed on all results, with P < 
0.05 considered as significant.
3. Result and discussion
3.1. Preparation of electrospun porous pH-responsive PU membrane
  
Interconnected porous PU membranes were fabricated by electrospinning. Various 
mixing ratios of DMF and THF (10:0, 7:3, 5:5, and 3:7) were applied to optimize the 
electrospinning condition of pH-responsive PU membranes (Fig. 1A-D). Electrospinning 
parameters such as the concentration of PUs, the voltage applied on the nozzle, feeding speed of 
the PU solution, nozzle-to-collector distance, and dispensed volume of the pH-responsive PU 
solution were fixed. The electrospun fibrous structure was fabricated with fine DIs when the 
DMF ratio was decreased in the mixed solvent (Fig. 1). Membranes fabricated by using a higher 
concentration of DMF (DMF:THF = 10:0 and 7:3) exhibited beaded fibrous structures (Fig. 1A-
B); however, a uniform fibrous structure was observed for the membranes with an increase in the 
THF content (DMF:THF = 5:5 and 3:7) (Fig. 1C-D). The quality and DI of electrospun fibers 
depend on the boiling point of the solvent. As THF has a lower boiling point, it can evaporate 
more rapidly than DMF, thus resulting in an increased amount of fine fibers with an increase in 
the THF ratio in the mixed solvent [45,46].
Pore size and DI of fibers (n = 100) were evaluated using ImageJ (Supplemental Fig. 
S.1). Average pore sizes of the membranes fabricated using different solvent ratios (DMF:THF = 
10:0, 7:3, and 5:5) were 2 ± 1 μm, 1.7 ± 0.6 μm, and 1.8 ± 0.6 μm, respectively. The average 
fiber DI of the membranes fabricated using DMF:THF = 5:5 was 5 ± 2 μm. On the other hand, 
the membrane fabricated using a higher ratio of THF in the mixed solvent (DMF:THF = 3:7) 
showed the greatest average pore size (2.1 ± 0.7 µm), the smallest average fiber DI (1.1 ± 0.5 
µm), and the narrowest distribution of the DI. As the membranes fabricated with a higher content 
of THF in the mixed solvent (DMF:THF = 3:7) showed the most uniform fibrous porous 
structure, they were used for further studies on pH-responsive morphology changes, NP release, 
and in vitro cytotoxicity. The viscosity of 20 wt% PEG-HEP-MDI-PG in a mixed solvent 
  
(DMF:THF = 3:7) was 0.306 ± 0.003 Pa.s. Viscosity is one of the important factors for 
electrospinnability. Polymers need to reach a certain threshold molecular weight as reflected by 
the viscosity of their solutions to get enough entanglement for fiber formation. The PU solution 
had a sufficiently high viscosity (0.306 ± 0.003 Pa.s.), thereby allowing it to be stretched into 
continuous fibers. It is important to note that a higher molecular weight polymer or higher 
solution concentration will lead to an increase in viscosity and greater fiber DI.
The morphology changes in electrospun porous pH-responsive (DMF:THF = 3:7) and 
control PU membranes under dry and wet conditions (pH 4.5 and 7.0) were evaluated on the 
basis of changes in the average pore size, average DI of fibers, and the thickness of the 
membranes (Fig. 2, Table 1). Pore size, fiber DI, and thickness of membranes were evaluated 
from micrographs taken using an SEM (magnification: ×1,000) using ImageJ. Pore sizes 
evaluated from the surface of the electrospun membranes might be different from those of the 
real situation for NP penetration because the actual membrane would have more layers than 
those shown in the SEM images. Average pore sizes of porous pH-responsive PU membranes 
under dry condition, pH 4.5, and pH 7.0 were 2.3 ± 0.7 μm, 1.8 ± 0.6 μm, and 2.2 ± 0.6 µm, 
respectively (Supplemental Fig. S.2). Average DIs of fibers of porous pH-responsive membranes 
under dry condition, pH 4.5, and pH 7.0 were 0.9 ± 0.4 μm, 1.4 ± 0.5 μm, and 1.2 ± 0.5 μm, 
respectively. The difference in the pore sizes of porous pH-responsive PU membranes at pH 4.5 
and 7.0 was 0.4 μm; however, the control PU membrane showed a difference of 0.2 µm between 
pH 4.5 and 7.0. The porous pH-responsive PU membrane had a smaller pore size at pH 4.5 than 
at pH 7.0 owing to the pH-responsive swelling of electrospun fibers. The fiber DI of the pH-
responsive membrane was 0.2 µm larger at pH 4.5 than at pH 7.0. The swollen fiber might 
occupy space between fibers and reduce pore sizes. The pH-responsive swelling of the fibers 
  
contributes not only to change in pore sizes but also to increased membrane thickness. The 
thickness of the porous pH-responsive membrane showed noticeable differences at pH 4.5 (50 ± 
2 μm) and pH 7.0 (35 ± 1 μm). At pH 4.5, the thickness of the porous pH-responsive membrane 
was 1.47 times greater than that at pH 7.0 owing to the protonation of pH-sensitive groups.[28] 
Such pH-responsive morphology changes contributed to pH-responsive PSN permeability as 
described in the following sections.
Zeta-potentials of control PU (PEG-HD-MDI-HD) and porous pH-responsive PU (PEG-
HEP-MDI-PG) membranes (DMF:THF = 3:7) were calculated from the streaming current at pH 
values ranging from 3.5 to 8.5 (Fig. 3). The control PU membrane showed an isoelectric point at 
pH 3.9. It showed a desirable zeta-potential profile as a control membrane, with negative values 
in pH range of 3.9 to 8.5, compared to the porous pH-responsive membrane. The zeta-potential 
of the control PU membrane was -7.9 mV at pH 4.5 and -25.4 mV at pH 7.0. The negatively 
charged surface has no attractive electric force, but it has repulsive electric force. However, the 
porous pH-responsive PU membrane may have strong attractive forces with anionic NPs at pH 
4.5 due to the positively charged surface at pH 4.5 (14.2 mV). The isoelectric point of the porous 
pH-responsive membrane was pH 7.2, and the membrane showed zeta-potential close to zero 
(2.2 mV) at pH 7.0. The porous pH-responsive PU membrane can have a strong electric 
attractive force at normal pH of the human vaginal tract (pH 3.5-4.5) and almost no electrostatic 
force at neutral pH (elevated pH of the vaginal tract resulting from the introduction of seminal 
fluid during heterosexual intercourse).
The electrospun porous PU membrane can be used as a semi-permeable membrane in 
reservoir-IVRs for pH-responsive release of NPs as illustrated in Fig. 4. Briefly, a reservoir-IVR 
can be made of water-swellable non-pH-responsive PU, and the reservoir can be filled with an 
  
NP suspension. The suspension of NPs would be recommended to avoid air bubbles in the 
reservoir and achieve fast out-diffusion of NPs due to pH change, i.e., fast pH-responsiveness. In 
addition, a reservoir-IVR with medical grade PUs composed of two parts, i.e., the IVR itself and 
two capsules made up of resin at opposite sides of the ring, can be fabricated using the 
electrospun porous PU membranes (Supplemental Fig. S3). Each capsule can be filled with NPs, 
and the electrospun pH-responsive PU membrane can be used to seal the top of the capsule. The 
membrane can be secured at the top by another fenestrated resin cap using medical grade glues to 
achieve the pH-responsive release of the NPs.
The electrospun pH-responsive PU (PEG-HEP-MDI-PG) membrane showed a positively 
charged surface and a larger DI of electrospun fibers, thicker cross-section, and smaller pore size 
at pH 4.5 than at pH 7.0. This is because the pH-sensitive molecule HEP (pKa 6.4) on the 
prepolymer chain of the PU was protonated at pH 4.5 and de-protonated at pH 7.0 [25]. 
Protonated HEP causes the electrospun fibers to swell more at pH 4.5. The higher swelling ratio 
leads to the larger DI of fibers, therefore leading to a thicker cross-section and a smaller 
interfiber pore size. Overall, the “window” membrane (electrospun porous pH-responsive PU 
membrane) can control the release of the NPs from the reservoir by a pH-responsive change in 
the electrostatic interaction between loaded NPs and morphologies (pore size and thickness of 
the membrane).
3.2. pH-responsive nanoparticle release studies using a model nanoparticle (PSNs)
Anti-HIV drugs and siRNAs can be loaded into the nanocarriers through hydrophobic or 
electrostatic interactions. Commercially available blue-dyed PSNs, the surfaces of which were 
modified to bear the carboxylic group (COOH), were used for NP release studies as a model 
nanocarrier. The PSNs could be a model NP of siRNA-loaded nanocarriers with a negatively 
  
charged surface, such as NPs, fabricated using PLGA-PEG-COOH and PVA by a double-
emulsion solvent evaporation method [17,47–49]. Moreover, PSNs have been used as a model 
nanocarrier for in vitro mucus penetration [50] and cellular uptake [51–54] studies. The PSNs 
showed narrow polydispersity in VFS (0.23 ± 0.02 and 0.04 ± 0.01 at pH 4.5 and 7.0, 
respectively) and could be observed with the naked eye. The average particle size and zeta-
potential of PSNs were measured at pH 4.5 and 7.0 (Table 2). These PSNs showed a minor 
difference in average zeta-potential and hydrodynamic particle size, at pH 4.5 (-16 ± 3 mV, 174 
± 1 nm) and at pH 7.0 (-20 ± 4 mV, 215 ± 2 nm), due to the deprotonation of the carboxylic 
groups at pH 7.0.[55]
In vitro PSN release studies were performed using porous pH-responsive (PEG-HEP-
MDI-PG) (DMF:THF = 3:7) and control (PEG-HD-MDI-HD) PU membranes (Fig. 5). The pH-
responsive PSN permeability of the porous pH-responsive PU membrane is distinguished from 
PSN release profile of the control PU membrane (Fig. 5A, 5B). These porous pH-responsive 
membranes revealed close-to-zero release of PSNs at pH 4.5; however, they showed sustained 
release of PSNs at pH 7.0 (Fig. 5B, 5C). At pH 7.0, 60 ± 6% of the feed amount of PSNs (0.8 
mL of 1 mg/mL PSNs) was released after 24 h. There was a rapid release of PSNs at pH 7.0 for 3 
h (51 ± 5%) driven by the relatively larger difference in concentration between the upper and 
bottom chambers of Franz cells. Such pH-responsive release of anionic NPs has two principal 
mechanisms. First, changes in the electrostatic interaction between the NPs and the electrospun 
porous pH-responsive membranes at pH 4.5 and pH 7.0 could lead to the pH-responsive NP 
release. The zeta-potential of the porous pH-responsive membrane was positive (14.2 mV) at pH 
4.5 and close-to-zero at pH 7.0 (2.2 mV) because the conjugate acid of the pH-sensitive moiety 
piperazine has a pKa of 6.5. The porous pH-responsive membrane had an electrostatic 
  
interaction with anionic PSNs at acidic pH (pH 4.5) but almost no electrostatic interaction at 
neutral pH. Second, morphology changes in the membrane at pH 4.5 and pH 7.0 contributed to 
the pH-responsive release of NPs. The porous pH-responsive PU membrane was thicker at pH 
4.5 (50 ± 2 µm) than at pH 7.0 (34 ± 1 µm), with a smaller pore size at pH 4.5 (1.8 ± 0.6 µm) 
than at pH 7.0 (2.2 ± 0.6 µm) due to the swelling of the electrospun pH-responsive PU fibers.
The intravaginal pH change by seminal fluid occurs immediately after the ejaculation of 
semen [20–22]. According to Tevi-Bénissan et al., full vaginal elimination of semen takes 20 h, 
and the vaginal ecological microenvironment returns to its normal acidic pH 48 h after 
intercourse [20]. It is inferred that the elevated pH could be maintained around neutral for at least 
a couple of hours because the sperm needs an alkaline or neutral environment to be able to 
survive and swim to fertilize the egg [23,24]. The pH-responsive PU membranes allowed the 
rapid release of PSNs at pH 7.0 for 2 h (30 ± 4%). This result reveals that the pH-responsive PU 
membranes have a potential use serving as a “window” membrane of IVRs for the on-demand 
release of nanocarriers. Additionally, the PSN release study was performed at pH 5.5 as an 
intermediate pH of 4.5 and 7.0 for further assessment of the pH-responsive release. The results of 
PSN release studies at pH 5.5 showed around a middle point between pH 4.5 and 7.0 in the case 
of the control PU membrane (52 ± 2% for 24 h). For the pH-responsive PU membrane, 
increasing pH from 4.5 to 5.5 allowed PSNs to start to pass through the membrane. However, the 
24 h release percentage was 22 ± 2%, which was only one-third of the release at pH 7.0 (60 ± 
6%). This result correlates well with the zeta-potential of the membrane. At pH 5.5, the pH-
responsive PU membrane was still positively charged as reflected by its zeta-potential of 10.5 
mV at pH 5.5 (closer to 14.2 mV at pH 4.5 than 2.2 mV at pH 7.0) and exerted an attractive 
electric force on PSNs, thereby restricting their release across the membranes. On the other hand, 
  
the cumulative amount of the PSNs released from the control membranes was found to be 32 ± 
6% at pH 4.5, 52 ± 2% at pH 5.5, and 67 ± 5% at pH 7.0 for 24 h. According to these results, the 
control membrane did not show the desired pH-responsive on-demand release of PSNs.
To better explain the pH-responsive release of PSNs, the association between the 
electrospun PU (porous pH-responsive and control) membrane and the PSN was evaluated (Fig. 
6). Round membrane samples (DI: 0.8 cm) were prepared and immersed in 6.4 mL of 0.125 
mg/mL PSN suspension at 37 °C with gentle horizontal shaking (100 rpm). These PSNs showed 
a relatively constant difference (12 ± 3%) in the number associated with the porous pH-
responsive membrane between pH 4.5 and pH 7.0 for 24 h. Such difference resulted from 
changes in the electrostatic interaction between porous pH-responsive membrane and PSNs, as 
well as changes in the morphology of the membrane. Although the average pore size at pH 4.5 
(1.8 ± 0.6 µm) was smaller than that at pH 7.0 (2.2 ± 0.6 µm), the strong electric attractive force 
at pH 4.5 might have caused a higher amount of PSN to be associated with the porous pH-
responsive membrane than that at pH 7.0. The control membrane showed the lowest amount of 
associated PSN at pH 7.0 because of the strong repulsion force between the negatively charged 
control membrane surface (-25.4 mV) and PSNs (-20 ± 4 mV). The repulsion force at pH 7.0 
might have hindered the penetration of PSNs through the control PU membrane at an early stage 
of penetration by preventing PSNs from approaching close to the membrane surface.
To further assess the pH-responsive release of NPs, release profiles of PSNs were 
recalculated using the following equation:
𝑎 (%) =
𝑏
𝑐 ‒ 𝑑 × 100
where  is the % of released PSNs at each time point,  is the released amount of PSNs (µg) in 𝑎 𝑏
the bottom chamber,  is the feed amount of PSNs to the upper chamber (µg), and  is the 𝑐 𝑑
  
amount of PSNs associated with the membrane (µg). Deducting the amount of adsorbed NPs 
allows us to take a close look at the diffusion of PSNs in their free unbound form. After the 
deduction, there was a continuous release of free PSNs at pH 7.0 for 24 h. However, there was 
close-to-zero release at pH 4.5 (4 ± 4%) for 24 h through the porous pH-responsive PU (PEG-
HEP-MDI-PG) membrane (Fig. 7). The control PU membrane showed a minor difference in the 
cumulative release of PSNs (36.7% at 24 h) compared to porous pH-responsive PU membrane. 
The difference in the release of PSNs between pH 4.5 and pH 7.0 through the control PU 
membrane could be due to the difference in the surface charge of the control PU at pH 4.5 and 
7.0. The control PU has a much more negative zeta-potential at pH 7.0 (-25.4 mV) than at pH 4.5 
(-7.9 mV) as shown in Figure 3. A much stronger Coulomb repulsion exists between PSNs and 
the control PU membrane at pH 7.0 than at pH 4.5 and contributes to accelerated NP penetration 
through the membrane.
3.3. pH-responsive nanoparticle release studies using CCR5 siRNA-encapsulated SLNs
To further demonstrate the utility of the electrospun pH-responsive PU membrane (PEG-
HEP-MDI-PG) in achieving pH-responsive intravaginal delivery of nanomedicines, CCR5 
siRNA-encapsulated-SLN was prepared by the emulsion solvent diffusion method and used for 
pH-responsive release study. The prepared CCR5 siRNA-encapsulated SLNs had a mean size of 
267 ± 32 nm, with a zeta potential of -19 ± 5 mV at 5 µg/mL in distilled water. The siRNA 
encapsulation efficiency was 67.6%, which was determined using the formula EE% = [{amount 
of total siRNA (µg)-amount of unencapsulated siRNA (µg)} / {amount of total siRNA (µg)}] × 
100
The electrospun pH-responsive PU membrane showed a significantly higher release of 
CCR5 siRNA-encapsulated SLNs at pH 7.0 (59 ± 8%) than at pH 4.5 (28 ± 4%) after 24 h of 
  
incubation (Fig. 8). This pH-responsive release can also be explained by the difference in 
electrostatic interaction between the membrane and CCR5 siRNA-encapsulated SLNs and 
morphologies of the membrane at pH 4.5 and pH 7.0. Compared to the release of PSNs, CCR5 
siRNA-encapsulated SLNs presented a burst release of 21 ± 4% (1 h) at pH 4.5 instead of close-
to-zero release. Moreover, SLNs were released much faster (51 ± 5%) than PSNs (4 ± 1%) at pH 
7.0 for 1 h. This result reveals that the CCR5 siRNA-encapsulated SLNs has much higher 
penetration efficiency through the membrane than PSNs, which may be due to the difference in 
physicochemical characteristics such as hydroxyl groups on SLN and carboxylic groups on 
PSNs.
Again, the electrospun pH-responsive membrane demonstrated their potential use in the 
smart intravaginal release of nanomedicines, although further optimization is necessary to 
achieve pH-responsive on-demand release (no release at the normal acidic pH of the vaginal tract 
and triggered release at elevated pH) of the therapeutic NP-CCR5 siRNA-encapsulated SLN.
3.4. In vitro cytotoxicity studies of the electrospun pH-responsive PU (PEG-HEP-MDI-PG) 
membrane
The human vaginal epithelial cell line “VK2/E6E7” and the human T-cell line “Sup-T1” 
were used for an in vitro cytotoxicity assay of electrospun porous pH-responsive PU membranes 
considering their potential application as “window” membranes in reservoir-IVRs for the pH-
responsive release of NPs, which may serve as nanocarriers for anti-HIV drugs and siRNAs. 
Electrospun porous pH-responsive PU (PEG-HEP-MDI-PG) membrane elution medium that was 
used to treat the cells did not present a cytotoxicity effect compared to the positive control (Fig. 
9). We also evaluated the production of pro-inflammatory cytokines (IL-6, IL-8, and IL-1β) after 
treating the cells with the elution medium, and the obtained results are shown in Fig. 10. 
Compared to the positive controls induced by the LPS and N-9, the PU membrane eluent did not 
generate significant changes in the expression of the pro-inflammatory markers, suggesting that 
the membranes did not induce an inflammatory microenvironment.
4. Conclusion
The pH-responsive interconnected porous PU membrane was fabricated by 
electrospinning using a pH-responsive PU (PEG-HEP-MDI-PG) copolymer. The porous pH-
  
responsive membranes showed pH-dependent changes in morphology (pore sizes, fiber DIs, and 
thickness) and surface charge. Such porous pH-responsive PU membranes demonstrated pH-
dependent release of color-dyed PSNs (-COOH) and CCR5 siRNA-encapsulated SLNs. There 
was close-to-zero release of PSNs in VFS at pH 4.5 (normal pH of the female genital tract). At 
pH 7.0, the release of PSNs significantly increased to 60 ± 6% in VFS at neutral pH (elevated pH 
of the female genital tract). Similarly, penetration of CCR5 siRNA-encapsulated SLNs through 
the PEG-HEP-MDI-PG membrane was more than twofold as much at pH 7.0 as at pH 4.5. The 
electrospun porous pH-responsive PU membrane showed no noticeable toxicity to human 
vaginal epithelial cell line (VK2/E6E7) and human T-cell line (Sup-T1). In addition, the elution 
medium collected from the membranes did not induce an inflammatory microenvironment. 
Overall, the newly electrospun porous pH-responsive PU membrane demonstrated potential use 
as a novel biomaterial for “smart” intravaginal delivery of therapeutic NPs.
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Figure legends
Fig. 1 SEM images of electrospun pH-responsive PU (PEG-HEP-MDI-PG) membranes at a 
voltage of 30 kV and PU concentration of 20 wt%. The volume ratios of DMF:THF were (A) 
10:0, (B) 7:3, (C) 5:5, and (D) 3:7. Scale bars are shown in the images.
Fig. 2 Morphology of electrospun porous pH-responsive PU (PEG-HEP-MDI-PG) membranes 
(DMF:THF = 3:7): dry (A), pH 4.5 (B), pH 7.0 (C), and control PU (PEG-HD-MDI-HD) 
  
membranes: dry (D), pH 4.5 (E), pH 7.0 (F). Scale bars are shown in the images.
Fig. 3 Influence of streaming pH on the zeta-potential of the electrospun PU membranes at pH 
ranging from 3.5 to 8.5. (A) Control PU (PEG-HD-MDI-HD) membrane and (B) porous pH-
responsive PU (PEG-HEP-MDI-PG) membrane. Data are expressed as mean ± SD; n = 3. Zeta-
potential was calculated using the Helmholtz–Smoluchowski equation.
Fig. 4 Diagram of the proposed use of the electrospun porous pH-responsive PU membrane as a 
“window” membrane in reservoir-IVR for controlled release of anionic nanoparticles release: 
(A) IVR; (B) window membrane; (C) reservoir. pH-responsive change in electrostatic interaction 
between the pH-responsive membranes and the anionic nanoparticles and morphology of the 
membrane contribute to the smart release of nanoparticles.
Fig. 5 In vitro nanoparticle permeation studies of (A) control PU (PEG-HD-MDI-HD) 
membrane, (B) porous pH-responsive PU (PEG-HEP-MDI-PG) membrane, and (C) photo of the 
study using porous pH-responsive PU (PEG-HEP-MDI-PG) membrane by Franz cells. 
Cumulative release of the nanoparticle in percentage (%) for 24 h was evaluated at pH 4.5, pH 
5.5, and pH 7.0. Anionic blue-dyed nanoparticles (PSNs, 200 nm) were used. Temperature was 
maintained at 37°C. Data are expressed as mean ± SD; n = 3.
Fig. 6 Association of PSNs on electrospun control and porous pH-responsive PU membranes at 
pH 4.5, pH 5.5, and pH 7.0. Data are expressed as mean ± SD; n = 3.
Fig. 7 In vitro nanoparticle release profiles after deduction of the associated PSNs with 
membrane (A) control PU (PEG-HD-MDI-HD) membrane, (B) porous pH-responsive PU (PEG-
HEP-MDI-PG) membrane. Cumulative release of the nanoparticle in percentage (%) for 24 h 
evaluated at pH 4.5, pH 5.5, and pH 7.0. Data are expressed as mean ± SD; n = 3.
Fig. 8 In vitro permeation studies of CCR5 siRNA-encapsulated SLNs through porous pH-
  
responsive PU (PEG-HEP-MDI-PG) membrane in VFS. Cumulative release of the CCR5 
siRNA-loaded SLNs in percentage (%) for 24 h was evaluated at pH 4.5 and pH 7.0. 
Temperature was maintained at 37°C. Data are expressed as mean ± SD; n = 3.
Fig. 9 In vitro biocompatibility of porous pH-responsive PU (PEG-HEP-MDI-PG) membrane 
tested with VK2/E6E7 and Sup-T1 cells. MTS assay was conducted for analyzing cell viability. 
Data are normalized to the negative control and expressed as mean ± SD; n = 3. One-way 
analysis of variance was performed for all results, with p < 0.05 considered as significant. 
Negative control includes the cells cultured in the medium only. To induce cell death in positive 
control, 1 M acrylamide dissolved in regular cell culture medium was used. N: negative control, 
P: positive control.
Fig. 10 Impact of porous pH-responsive PU (PEG-HEP-MDI-PG) membranes on 
proinflammatory cytokine production (A) Interleukin IL-1β, (B) IL-6, and (C) IL-8 production. 
Negative control was a plain medium, and positive control was 200 µg/mL of nonoxynol-9 or 50 
µg/mL of lipopolysaccharide-treated cells for IL-1β and IL-6/IL-8, respectively. Data are 
expressed as mean ± SD; n = 3. One-way analysis of variance was performed for all results, with 
p < 0.05 considered as significant. N: negative control, P: positive control.
Table 1. Average pore size and diameter of electrospun porous pH-responsive (PEG-HEP-MDI-
PG) and control (PEG-HD-MDI-HD) PU membranes under dry and wet conditions in VFS at pH 
4.5 and 7.0.
Dry pH 4.5 pH 7.0
Average pore size (µm) 2.3 ± 0.7 1.8 ± 0.6 2.2 ± 0.6
Average diameter of fibers (µm) 0.9 ± 0.4 1.4 ± 0.5 1.2 ± 0.5
pH-responsive
(PEG-HEP-MDI-PG)
Average thickness (μm) 28.6 ± 0.7 50 ± 2 35 ± 1
Average pore size (µm) 2.0 ± 0.6 1.5 ± 0.4 1.7 ± 0.4Control
(PEG-HD-MDI-PG) Average diameter of fibers (µm) 0.7 ± 0.2 0.9 ± 0.3 0.8 ± 0.2
  
Table 2. Physicochemical characteristics of blue-dyed polystyrene nanoparticles (PSNs) (data 
are expressed as mean ± SD; n = 3).
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Statement of Significance
Stimuli-responsive intravaginal nanoparticle release is achieved for the first time through new 
electrospun pH-responsive polyurethane (PU) semi-permeable membranes, which serve as a 
Average thickness (μm) 22.9 ± 0.8 29 ± 2 25.0 ± 0.9
pH 4.5 pH 7.0
Particle size (nm, 0.1 µg/mL) 174 ± 1 215 ± 2
Zeta potential (mV, 0.1 µg/mL) -16 ± 3 -20 ± 4
  
“window” membrane of the reservoir-type intravaginal ring (IVR) for the prevention of human 
immunodeficiency virus (HIV) transmission. Almost no release of nanoparticles was observed at 
normal pH in the female genital tract (in vaginal fluid simulant [VFS], at pH 4.5); however, a 
continuous release of nanoparticles was observed at elevated pH in the female genital tract (in 
VFS, at pH 7.0). This pH-responsive intravaginal release can reduce side effect and drug 
resistance by avoiding unnecessary exposure. The PU semi-permeable membrane demonstrated 
potential use as biomaterials for “smart” intravaginal nanoparticle release and has great potential 
to protect women from HIV.
  
Fig. 1 SEM images of electrospun pH-responsive PU (PEG-HEP-MDI-PG) membranes at a 
voltage of 30 kV and PU concentration of 20 wt%. The volume ratios of DMF:THF were (A) 
10:0, (B) 7:3, (C) 5:5, and (D) 3:7. Scale bars are shown on the images.
  
  
Fig. 2 Morphology of electrospun porous pH-responsive PU (PEG-HEP-MDI-PG) membranes 
(DMF:THF = 3:7): dry (A), pH 4.5 (B), pH 7.0 (C), and control PU (PEG-HD-MDI-HD) 
membranes: dry (D), pH 4.5 (E), pH 7.0 (F). Scale bars are shown on the images.
Fig. 3 Influence of streaming pH on the zeta-potential of the electrospun PU membranes at pH ranging 
from 3.5 to 8.5. (A) Control PU (PEG-HD-MDI-HD) membrane and (B) porous pH-responsive PU (PEG-
HEP-MDI-PG) membrane. Data are expressed as mean ± SD; n = 3. Zeta-potential was calculated using 
the Helmholtz–Smoluchowski equation.
  
Fig. 4 Diagram of the proposed use of the electrospun porous pH-responsive PU membrane as a 
“window” membrane in reservoir-IVR for controlled release of anionic nanoparticles: (A) IVR; 
(B) window membrane; (C) reservoir. pH-responsive change in electrostatic interaction between the 
pH-responsive membranes and the anionic nanoparticles and morphology of the membrane contribute to the smart 
release of nanoparticles.
  
Fig. 5 In vitro nanoparticle permeation studies of (A) control PU (PEG-HD-MDI-HD) 
membrane, (B) porous pH-responsive PU (PEG-HEP-MDI-PG) membrane, and (C) photo of the 
study using porous pH-responsive PU (PEG-HEP-MDI-PG) membrane by Franz cells. 
Cumulative release of the nanoparticle in percentage (%) for 24 h was evaluated at pH 4.5, pH 
5.5, and pH 7.0. Anionic blue-dyed nanoparticles (PSNs, 200 nm) were used. Temperature was 
maintained at 37°C. Data are expressed as mean ± SD; n = 3.
  
Fig. 6 Association of PSNs on electrospun control and porous pH-responsive PU membrane at 
pH 4.5, pH 5.5, and pH 7.0. Data are expressed as mean ± SD; n = 3.
  
Fig. 7 In vitro nanoparticle release profiles after deduction of the associated PSNs with 
membrane (A) control PU (PEG-HD-MDI-HD) membrane, (B) porous pH-responsive PU (PEG-
HEP-MDI-PG) membrane. Cumulative release of the nanoparticle in percentage (%) for 24 h 
evaluated at pH 4.5, pH 5.5, and pH 7.0. Data are expressed as mean ± SD; n = 3.
Fig. 8 In vitro permeation studies of CCR5 siRNA-encapsulated SLNs through porous pH-
responsive PU (PEG-HEP-MDI-PG) membrane in VFS. Cumulative release of the CCR5 
siRNA-loaded SLNs in percentage (%) for 24 h was evaluated at pH 4.5 and pH 7.0. 
Temperature was maintained at 37°C. Data are expressed as mean ± SD; n = 3.
  
Fig. 9 In vitro biocompatibility of porous pH-responsive PU (PEG-HEP-MDI-PG) membrane 
tested with VK2/E6E7 and Sup-T1 cells. MTS assay was conducted for analyzing cell viability. 
Data are normalized to the negative control and expressed as mean ± SD; n = 3. One-way 
analysis of variance was performed for all results, with p < 0.05 considered as significant. 
Negative control includes cells cultured in the medium only. To induce cell death in positive control, 1 M 
acrylamide dissolved in regular cell culture medium was used. N: negative control, P: positive control.
  
Fig. 10 Impact of porous pH-responsive PU (PEG-HEP-MDI-PG) membranes on 
proinflammatory cytokine production (A) Interleukin IL-1β, (B) IL-6, and (C) IL-8 production. 
Negative control was a plain medium, and positive control was 200 µg/mL of nonoxynol-9 or 50 
µg/mL of lipopolysaccharide-treated cells for IL-1β and IL-6/IL-8, respectively. Data are 
  
expressed as mean ± SD; n = 3. One-way analysis of variance was performed for all results, with 
p < 0.05 considered as significant. N: negative control, P: positive control.
